How a 20-Minute Eye-Tracking Evaluation Helps Families Get Autism Answers Years Sooner

Learning Success infographic titled Precision Vision: How Eye-Tracking Helps Identify Autism Earlier. It explains that eye-tracking evaluations measure three core areas, social engagement, verbal ability, and non-verbal learning, and notes the approach agreed with expert clinicians about four out of five times in large studies of toddlers, validated across feasibility and pivotal trials. It lists steps for parents: trust your instincts, ask your pediatrician about objective screening tools, and seek early support. The footer reads that earlier identification opens doors to earlier support when developing brains are most responsive to intervention.

You noticed it before anyone else did. The way your toddler looks past faces instead of into them, the name called three times with no turn, the pointing that never quite arrived. You mentioned it at a checkup and heard ‘let’s wait and see,’ or you booked an evaluation and learned the next opening is months away. That waiting is its own kind of ache, the sense that something matters and the clock is running while everyone tells you to relax. You are not imagining it, and you are not alone: across the country, families wait on average close to three years from a first worry to an autism assessment, and the typical child is not identified until around age four, long after a parent first knew to ask.

TL;DR

Eye-tracking evaluations measure how a young child's gaze responds to social scenes to flag patterns linked with autism, often years before a traditional evaluation happens.
The EarliPoint Evaluation is the first FDA-authorized eye-tracking tool to help clinicians assess autism in children as young as 16 months, in under 20 minutes.
In a 2023 JAMA study of about 475 toddlers, the system agreed with expert clinicians roughly four times out of five.
It is an aid to a qualified clinician's diagnosis, not a diagnosis on its own, and a full professional evaluation is still the route to services.
Earlier identification matters because support tends to do the most good while the developing brain has the most runway ahead of it.

Common questions from parents

What is the earliest age autism is identified?

Experienced professionals reliably identify autism by around age two, and the American Academy of Pediatrics recommends screening at 18 and 24 months. Newer eye-tracking tools are authorized for children as young as 16 months. Most children, though, are not identified until close to age four, often long after a parent first noticed something.

Is an eye-tracking test the same as an autism diagnosis?

No. The EarliPoint Evaluation is authorized as a tool to aid a qualified clinician, not as a standalone diagnosis. A result is a starting point, not a verdict. If your child might need formal accommodations through an IEP or 504 plan, or you suspect a vision, hearing, or medical cause, pursue a comprehensive professional evaluation, which is the only route to those supports.

How accurate is the eye-tracking evaluation?

In a 2023 study published in JAMA with about 475 toddlers, the system agreed with expert clinicians roughly four times out of five, with sensitivity and specificity in the low-to-high 80 percents across samples. No screening tool is perfect, which is why results are read alongside a clinician’s full assessment rather than on their own.

Should I wait and see, or ask for an evaluation now?

Trust what you have observed. If you notice developmental differences, voicing your concern early is reasonable, and you lose nothing by asking. You know your child across every setting and every day, which is exactly the perspective a clinician needs.

Most kids aren't identified with autism until age 4, though parents often knew sooner. New eye-tracking tools help clinicians reach answers years earlier, and never replace a full evaluation. Tweet Now Follow Learning Success

What the Eye-Tracking Evaluation Actually Measures

The tool in this infographic is the EarliPoint Evaluation, the first eye-tracking system the FDA authorized to help clinicians assess autism in children as young as 16 months. A child watches short videos of everyday social scenes on a screen while sensors record exactly where the eyes go, moment by moment. In under 20 minutes it gathers data that a team of specialists would otherwise spend hours assembling. Here is what it tracks, in plain terms:

Social engagement: how much a child’s gaze is drawn to faces, eyes, and the give-and-take of interaction, rather than to objects or background.
Verbal patterns: visual-attention signatures that tend to track with where a child is in early language development.
Non-verbal learning: how a child takes in and responds to visual information in a scene.

In the pivotal study published in JAMA in 2023, researchers tested the system against expert clinical diagnosis in roughly 475 children aged 16 to 30 months. It agreed with the specialists about four times out of five, with sensitivity and specificity landing in the low-to-high 80 percents across the discovery and replication samples. One detail matters more than any single number: the evaluation is built to support a qualified clinician’s judgment, not to hand down a verdict on its own.

Author Quote “

A waitlist is not a verdict on your instincts. If you noticed something, that noticing already matters, and the tools exist now to help you act on it sooner.

”

Why Reaching Families Sooner Changes the Story

The reason early matters is not that an earlier label fixes anything by itself. It is that the toddler brain is wired for change, and the window when support meets a developing brain is when that support tends to do the most good. The American Academy of Pediatrics recommends autism screening at 18 and 24 months for a reason: signs are observable, and an experienced professional reliably identifies autism by around age two. Yet the average child in the United States is not identified until about 47 months, and families often wait years between the first worry and a full assessment. That gap is not a parenting failure. It is a system that runs short on specialists and long on waitlists.

An objective tool shortens that gap in two ways. It gives a busy pediatrician something concrete to act on instead of ‘let’s watch it,’ and it gives families quantifiable information rather than a shrug. Earlier understanding means earlier support, and the developing brain tends to be most responsive to that support in these early years. None of this means the brain stops changing later. Neuroplasticity keeps the door open at every age. It means the door opens widest when a child has the most runway ahead of them.

Key Takeaways:

Gaze is data: where a toddler looks during social scenes carries measurable signals about how they are developing, which is what eye-tracking turns into objective information.

A tool, not a verdict: the eye-tracking evaluation aids a clinician's judgment and never replaces a comprehensive professional assessment.

Sooner means more runway: identifying support needs earlier lets families start while the developing brain tends to be most responsive.

A Result Is a Starting Point, Not a Verdict

Here is the part the infographic understates. An eye-tracking score is one piece of information, not a diagnosis on its own. The FDA authorized the EarliPoint Evaluation as a tool to aid a qualified clinician, used alongside a full developmental history, observation, and a parent’s account of how their child engages at home. A number on a screen describes how a child looked at a set of videos on one day. It does not capture who your child is, how they connect with you, or who they are growing into.

So treat any screening or assessment result the way you would treat a map, not a sentence. It tells you where to start. If your child might need formal services or accommodations through an IEP or 504 plan, or if you suspect a vision, hearing, or medical cause behind what you are seeing, a comprehensive professional evaluation is the route to those supports, and worth pursuing regardless of what any single tool reports. The goal of getting answers sooner was never to define your child faster. It was to start understanding and supporting them sooner.

In under 20 minutes, the evaluation gathers the kind of objective, quantifiable data on social visual engagement that a team of clinicians would otherwise spend hours assembling by observation alone. Adapted from Jones et al., JAMA, 2023.

Author Quote “

An eye-tracking score describes one morning of looking at videos. It will never describe the whole of who your child is, or who they are growing into.

”

At Learning Success, we start from a simple stance: your child is not broken, and a difference in how they engage with the world is information, not a defect. The real adversary is not your child’s wiring. It is the wait, the ‘let’s see how it goes,’ the years that slip by while a parent who already knew something stands at the back of a months-long line. You are not a bystander in that story. You are the person who noticed first, and the most informed advocate your child will ever have.

Getting answers sooner only helps if it leads to support that builds your child up. That is the work we care about: practical, strengths-based ways to help a child grow in confidence, communication, and the everyday skills that open doors, whatever a formal evaluation eventually shows.

Most children who learn differently are navigating more than one thing at once, which is why a single program rarely covers it. Our All Access membership gives families the full library of tools in one place, so you have support for the whole child while you wait, and well after the answers arrive.

References

Jones W, Klaiman C, Richardson S, et al. Eye-Tracking-Based Measurement of Social Visual Engagement Compared With Expert Clinical Diagnosis of Autism. JAMA. 2023;330(9):854-865.
U.S. Food and Drug Administration / EarliTec Diagnostics. EarliPoint Evaluation, authorized as a tool to aid clinicians in assessing autism in children 16-30 months.
Centers for Disease Control and Prevention, Autism and Developmental Disabilities Monitoring (ADDM) Network, 2025 (surveillance year 2022): median age of diagnosis approximately 47 months.
American Academy of Pediatrics: recommended autism screening at 18 and 24 months.
State of Autism Care report (Cognoa-sponsored), 2023: autism evaluation wait times.